menu search

Zyversa therapeutics announces publication in molecular neurobiology reinforcing data demonstrating that inflammasome asc inhibitor ic 100 attenuates the inflammatory response causing neuronal damage

Molecular Neurobiology publication demonstrated that NLRP3 inflammasomes have an important role in the pathogenesis of multiple sclerosis (“MS”) b...

November 1, 2023, 12:07 pm

Eisai presents new leqembi® (lecanemab-irmb) investigational subcutaneous formulation interim study results and clinical improvement data in earlier stages of early alzheimer’s disease from additional

Investigational Subcutaneous Formulation Clears 14% More Plaque Than IV, Pharmacokinetics (AUC) 11% Higher, And Similar ARIA Rates To IV 76% Of Patien...

October 25, 2023, 9:26 pm

Eisai presents new leqembi® (lecanemab-irmb) investigational subcutaneous formulation interim study results and clinical improvement data in earlier stages of early alzheimer’s disease from additional

Investigational Subcutaneous Formulation Clears 14% More Plaque Than IV, Pharmacokinetics (AUC) 11% Higher, And Similar ARIA Rates To IV 76% Of Patien...

October 25, 2023, 9:26 pm

Filament health jv magdalena biosciences kicks off preclinical study of plant extracts for mental health indications

Filament Health Corp (OTCQB:FLHLF, NEO:FH) said Magdalena Biosciences, its joint venture (JV) with Jaguar Health, has initiated a preclinical study o...

October 23, 2023, 9:03 am

Ptc therapeutics stock jumps on royalty deal worth up to $1.5 billion

PTC Therapeutics shares PTCT, -0.53% jumped 12% premarket on Thursday after the company announced a deal with Royalty Pharma PLC RPRX, -3.58% to monet...

October 19, 2023, 9:18 am

Brain stimulation highlights best practices for optimal tms treatment outcomes

Findings confirm strong correlation between the number of TMS treatment sessions completed and improvement in MDD MALVERN, Pa., Oct. 16, 2023 (GLOBE N...

October 16, 2023, 12:56 pm

Novartis leads funding round for uk alzheimer's specialist

UK-based biotech firm AstronauTx has secured £48 million ($61 million) in a significant Series A funding round, marking a step towards developing tre...

October 9, 2023, 2:16 am

neurona therapeutics announces publication in cell stem cell reporting the development of investigational novel regenerative cell therapy strategy for drug-resistant focal epilepsy

Publication demonstrates robust and reproducible generation of pure pallial, medial ganglionic eminence (MGE)-type GABAergic inhibitory inter...

October 5, 2023, 3:00 pm

neuronetics draws down remaining $22.5 million available under credit facility

MALVERN, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) — neuronetics, Inc. (NASDAQ: STIM), a commercial stage m...

October 3, 2023, 1:21 pm

Acumen pharmaceuticals: novel alzheimer's molecule with positive early data

Acumen Pharmaceuticals is developing a monoclonal antibody, ACU193, that targets Amyloid beta oligomers (AβOs) in Alzheimer's disease. AβOs are smal...

October 3, 2023, 5:15 am

neuronetics: large losses may be repelling investors

neuronetics is currently facing challenges from increased competition and a difficult macro environment...

September 6, 2023, 5:26 pm

Reneuron highlights exosome platform r&d progress

Reneuron said it had taken an important step forward with plans to differentiate its exosome platform b...

September 4, 2023, 3:43 am

Clene to present at upcoming september conferences

SALT LAKE CITY, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary...

August 30, 2023, 8:20 am

Gain therapeutics presents new preclinical data demonstrating a reduction of plasma neurodegeneration biomarker nfl after administration of its drug candidate gt-02287 in gba1 parkinson’s disease mode

Treatment with GT-02287 also restored glucocerebrosidase (GCase) enzymatic function, reduced aggregated α-synuclein, neuroinflammation and ...

August 28, 2023, 11:00 am

Praxis precision medicines to present analyses of patient-focused, clinically meaningful endpoints from essential1 study of ulixacaltamide in essential tremor at the 2023 mds international congress

BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating gene...

August 28, 2023, 7:00 am

neuronetics, inc. (stim) q2 2023 earnings call transcript

neuronetics, Inc. (NASDAQ:STIM ) Q2 2023 Earnings Conference Call August 8, 2023 8:30 PM ET Company Par...

August 8, 2023, 12:59 pm

neuron net gold ea mt5 : the forex trading powerhouse

neuron Net GOLD EA Review Welcome to the world of financial markets, where the only constant is change,...

July 28, 2023, 8:00 am

Eliem therapeutics' stock soars 21% premarket after company says it may sell itself

Eliem Therapeutics Inc.'s stock ELYM, -4.76% soared 21% in premarket trade Thursday, after the biotech, which specializes in therapies for ...

July 20, 2023, 6:57 am

neuronascent to present new parkinson’s model data at aaic 2023 for the alzheimer’s disease investigational therapy, nni-362

ROCKVILLE, Md., June 28, 2023 (GLOBE NEWSWIRE) — neuronascent Inc., today announced its abstract titl...

June 28, 2023, 10:00 am

Praxis precision medicines to present at the 2023 jefferies healthcare conference

BOSTON, June 02, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating gene...

June 2, 2023, 9:00 am


Search within

Pages Search Results: